Navigation Links
InterMune Reports Third Quarter 2009 Financial Results and Business Highlights
Date:11/5/2009

BRISBANE, Calif., Nov. 5 /PRNewswire-FirstCall/ -- InterMune, Inc. (Nasdaq: ITMN) today announced results from operations for the third quarter and nine months ended September 30, 2009. InterMune reported a net loss for the third quarter of 2009 of $8.8 million, or $0.19 per share, compared with a net loss of $14.0 million, or $0.36 per share, in the third quarter of 2008.

Dan Welch, Chairman, Chief Executive Officer and President of InterMune, said, "The third quarter and recent weeks have been a period of exceptional progress and accomplishment for InterMune. As announced yesterday, we submitted our New Drug Application (NDA) for pirfenidone, the first NDA ever submitted for a medicine for patients who suffer from idiopathic pulmonary fibrosis (IPF). We also made excellent progress on our hepatitis C virus (HCV) protease inhibitor ITMN-191 (RG7227) including the initiation of our Phase 2b clinical study and the presentation of the promising results of our novel clinical study of two direct antiviral agents, INFORM-1, at the AASLD meeting earlier this week." Mr. Welch continued, "Our efforts are now focused on the submission of the MAA for pirfenidone, the support of the NDA and the work to be prepared to bring pirfenidone to patients, should our NDA and/or MAA be granted approval by the regulatory authorities in the United States and Europe, respectively."

Results for the Three Months Ended September 30, 2009

InterMune reported total revenue in the third quarter of 2009 of $27.3 million, compared with total revenue of $23.3 million in the third quarter of 2008. Total revenue in the third quarter of 2009 primarily consisted of revenue from the collaboration with Roche for the development of protease inhibitors, including ITMN-191, which totaled $20.8 million in the third quarter of 2009, compared
'/>"/>

SOURCE InterMune, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13

Related medicine technology :

1. InterMune Announces Approval of Clinical Trial Authorization for Phase 1b Trial of ITMN-191
2. InterMune Announces Start of Phase 1b Trial of ITMN-191
3. InterMune Announces Top-Line Results of Phase 1b Trial of ITMN-191 (R7227) and Provides Program Update
4. InterMune Provides Additional Information on ITMN-191 (R7227) MAD Study Results
5. InterMune Announces Progress on Pirfenidone in IPF
6. InterMune Announces Receipt of Fast Track Designation for Pirfenidone From FDA
7. InterMune Announces Start of 14-Day Triple Combination Study of ITMN-191 in Patients With Chronic Hepatitis C
8. Roche, InterMune and Pharmasset Announce Initiation of INFORM-1, the First Dual-Combination Clinical Trial with Oral Antivirals in Hepatitis C
9. InterMune to Report Top-Line Results of Triple Combination Study of ITMN-191 in January 2009
10. InterMune to Conduct Conference Call and Webcast to Discuss Results of Triple Combination Study of ITMN-191
11. InterMune to Announce Results of Phase 3 CAPACITY Program of Pirfenidone in IPF Tomorrow, February 3
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/26/2014)... 26, 2014  Genomic Health, Inc. (Nasdaq: GHDX ... Chief Executive Officer and President, will participate in the ... The New York Palace Hotel in New ... am Eastern Time (ET). To access the ... go to the  Investor Relations  section of the company,s ...
(Date:11/26/2014)... 26, 2014  Over 100 million adults suffer from ... this pain daily. Chronic and acute pain dramatically impacts ... born to fulfill the need for non-surgical, interventional solutions ... On October 28th, a new pain management ... Maryland community.  This new facility boasts cutting ...
(Date:11/26/2014)... A hernia is condition in which ... the wall of a weak muscle area. Obesity, poor nutrition, ... of the causes of hernias. There are several types of ... inguinal hernia is when part of the abdominal tissue/organ protrudes ... the area of the umbilicus. A hiatal hernia is when ...
Breaking Medicine Technology:Genomic Health to Present at the 26th Annual Piper Jaffray Healthcare Conference 2Genomic Health to Present at the 26th Annual Piper Jaffray Healthcare Conference 3New Pain Management Center Opens in Cumberland, Md. 2Global Hernia Repair Devices Market Size, Share, Trends and Forecast 2014 to 2018 - Big Market Research 2Global Hernia Repair Devices Market Size, Share, Trends and Forecast 2014 to 2018 - Big Market Research 3Global Hernia Repair Devices Market Size, Share, Trends and Forecast 2014 to 2018 - Big Market Research 4
(Date:11/28/2014)... Florida (PRWEB) November 28, 2014 On ... Turbana and Sendik’s will present Feeding America Eastern Wisconsin ... Sendik’s Food Market to donate a portion of proceeds ... in Sendik’s promotion, “7 Days, 7 Ways to Save” ... fall, Fyffes pineapples were two for $4 and Turbana ...
(Date:11/28/2014)... Miami's Plastic Surgery of the Face recently introduced ... Jeffrey Epstein is excited to offer patients the ... the site is uniquely designed for easing viewing on ... of all prospective rhinoplasty patients research upcoming procedures online. ... with smartphones, tablets, and laptops, as well as the ...
(Date:11/28/2014)... Colorado (PRWEB) November 28, 2014 Written and ... , Brook Forest Voices releases the “The Happiest Man ... , a compelling account of how and why Project C.U.R.E. ... Idaho by his mother Josie and the Reverend Richard W. ... by the age of 30, but realized that he wasn’t ...
(Date:11/28/2014)... Not only is the Éminence Organic Skin Care team ... other cancer-causing agents, but they are also proud to ... that help in the fight against breast cancer. This ... record-breaking contribution of $30,000 through participation in the CIBC ... Rose Whip Moisturizer and the company’s corporate donation. , ...
(Date:11/28/2014)... 2014 Mabel’s Labels , the ... and an award-winning company established by four moms, today ... and Tricia Mumby have been honored with a 2014 ... the PROFIT Award for Excellence in Entrepreneurship. , All ... Tricia Mumby) accepted the award on behalf of Mabel’s ...
Breaking Medicine News(10 mins):Health News:Turbana Partners With Sendik's Food Market to Donate $11,500 to Local Hunger-Relief Non-Profit 2Health News:Turbana Partners With Sendik's Food Market to Donate $11,500 to Local Hunger-Relief Non-Profit 3Health News:Top Rhinoplasty Surgeon Launches Innovative Website 2Health News:Thanksgiving Weekend Audiobook Treat! “The Happiest Man In the World: Life Lessons From a Cultural Economist” by Dr. James W. Jackson 2Health News:Éminence Organic Skin Care Donates Record-breaking $30,000 to Breast Cancer Research 2Health News:Éminence Organic Skin Care Donates Record-breaking $30,000 to Breast Cancer Research 3Health News:Mabel's Labels’ Co-Founders Named A Winner In The 2014 RBC Canadian Women Entrepreneur Awards Program; A Second-Time Win For The Brand 2Health News:Mabel's Labels’ Co-Founders Named A Winner In The 2014 RBC Canadian Women Entrepreneur Awards Program; A Second-Time Win For The Brand 3
... Dennis Thompson HealthDay Reporter , FRIDAY, May ... often find themselves struggling to make sense of their ... way to treat the frightening and frustrating neurodevelopmental disorder. ... problems and repetitive behavior patterns. Each child will ...
... a way to combat their delirium, thanks to a $2.4 ... is prevalent in people with dementia," said Ann Kolanowski, Elouise ... our pilot study that many older adults who have dementia ... doesn,t necessarily resolve by the time they are discharged from ...
... widely prevalent in the animal kingdom. The reason we do ... to our body,s defence system, which manages to digest invading ... will only fall ill if he consumes more than 100.000 ... or meat. An international team of researchers, led by Prof. ...
... , FRIDAY, May 27 (HealthDay News) -- Julie Wismann knew her ... epilepsy at age 1 and put on medication, said Wismann, 34, ... her words. "At first we thought it was a speech ... from saying 50 words to no words. She was basically becoming ...
... (HealthDay News) -- Wide differences in care for people who,ve ... in the United States, according to a joint report issued ... "We see disparities in every aspect of stroke care, from ... delayed arrival to the emergency room and increased waiting time," ...
... given to pregnant and breast-feeding rats reduced the rate ... cent, a new study has found. The research, ... Michael,s Hospital, adds to the growing but sometimes contradictory ... can increase or decrease the development or progression of ...
Cached Medicine News:Health News:Complexities of Autism Extend to Its Treatment 2Health News:Complexities of Autism Extend to Its Treatment 3Health News:Intestinal cell defense mechanism against bacteria 2Health News:Living With a Child With Autism 2Health News:Living With a Child With Autism 3Health News:Experts Say Stroke Care Differs for U.S. Minorities 2Health News:Folic acid given to mother rats protects offspring from colon cancer 2
... Nephroscope, with a stainless steel shaft, combines ... lumbotome, for precise pre-cutting of scar tissue, ... access. The 13.5 Fr. oval working channel ... and lithotripsy probes, and allows a high ...
... first and only Laser Surgical device ... precisely. This innovative combination is used ... A Laser phacoemulsification device utilizes a ... and transmits it directly, and only, ...
... Capture ELISA is for the qualitative presumptive ... antigens (WNRA) in serum as an aid ... Nile virus infection in patients with clinical ... be confirmed by Plaque Reduction Neutralization Test ...
... retrograde to dilate the ... Peel-Away ureteral access conduit ... protective Peel-Away sheath can ... the ureteroscope is later ...
Medicine Products: